Center-Authored Papers

Filters: Author is Massard, Christophe  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2014
Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C et al..  2014.  Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(1):246-52. Abstract
Aged
Aged, 80 and over
Consortium Authored Paper
Drug Administration Schedule
Drug Resistance, Neoplasm
February 2014
Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C et al..  2014.  Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(1):246-52. Abstract
Gonadotropin-Releasing Hormone
Humans
Male
Middle Aged
Neoplasm Metastasis
Prostatic Neoplasms
Protein Kinase Inhibitors
Public Health Sciences Division
Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C et al..  2014.  Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(1):246-52. Abstract
Pyrimidines
Thiazoles